The European Medicines Agency (EMA) announced on 21 November the establishment of the Quality Innovation Group (QIG).
The QIG’s mission will be to support innovative approaches to the development, production and quality control of pharmaceutical products in the EU.
The expert group will be tasked with identifying innovative approaches to the production of pharmaceuticals and identifying and addressing gaps in the EU regulatory framework for these innovations. It will also help to ensure a...